Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARE-ICH
NCT07026994Phase 2Recruiting
- Sponsor
- Huashan Hospital
- Start
- Jun 2025
- Primary completion
- Dec 2027
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in cerebral amyloid angiopathy (CAA), sponsored by Huashan Hospital. Started Jun 2025; status: recruiting.
02
Drugs
colchicine
03
Conditions
cerebral amyloid angiopathy (CAA)
Beyond the preview
Go deeper on NCT07026994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07026994.